Logo
Search
Home
Posts
Tags
Podcast
Tools
Tools

Token Calculator

Peer Review’d

Claude Skills Playground

UK Tech Policy

AI Research

+6

OpenAI's GPT-Rosalind targets drug discovery, Anthropic's Claude Mythos heads to UK banks, and a robot brain learns on the fly

Apr 18, 2026

β€’

3 min read

OpenAI's GPT-Rosalind targets drug discovery, Anthropic's Claude Mythos heads to UK banks, and a robot brain learns on the fly

Plus Physical Intelligence's generalist robot model, AI traffic to retailers jumps 393%, and the UK's Β£500m sovereign AI fund gets its first investment

Copyright Law

+6

Google's Stitch launches vibe design, Meta's rogue AI agent problem, and the UK finally backs creators on copyright

Mar 20, 2026

β€’

3 min read

Google's Stitch launches vibe design, Meta's rogue AI agent problem, and the UK finally backs creators on copyright

Google enters the AI design space, Meta's agents leaked data they shouldn't have seen, and the UK reverses its controversial AI copyright stance

Apple Intelligence

+5

UK AI startup Synthesia hits $4bn valuation, Apple's Gemini-powered Siri coming February

Jan 27, 2026

β€’

3 min read

UK AI startup Synthesia hits $4bn valuation, Apple's Gemini-powered Siri coming February

Plus: ChatGPT now pulls from Grokipedia, science fiction writers reject AI, and concerns mount about AI's impact on UK jobs

UK Tech Policy

+5

AI Reality Outpaces Science Fiction: From UK Strategy to Hollywood's AI Dilemma

Aug 20, 2025

β€’

3 min read

AI Reality Outpaces Science Fiction: From UK Strategy to Hollywood's AI Dilemma

James Cameron admits real AI is moving faster than his Terminator plotlines, while the UK grapples with AI sovereignty

Daily Inference - AI Daily News πŸ€–

Your Daily Dose of Artificial Intelligence 🧠 From breakthroughs in machine learning to the latest AI tools transforming our world, AI Daily gives you quick, insightful updates - every single day.

Β© 2026 Daily Inference - AI Daily News πŸ€–.
Report abusePrivacy policyTerms of use
beehiivPowered by beehiiv